类泌尿腺癌:进展和挑战
Antonio Lopez-Beltran1, Alessia Cimadamore2, Ana Blanca1
1Department of Morphological Sciences, Cordoba University, Medical School, Cordoba.
Current opinion in urology
|January 8, 2026
概括
类泌尿腺癌是一种激进的膀癌亚型,越来越多地被理解为基底分子亚型. 这一发现支持针对性治疗,如免疫检查点抑制剂,以改善患者的治疗结果.
科学领域:
- 尿瘤学 尿瘤学
- 病理学 病理学 病理学
- 分子生物学分子生物学
背景情况:
- 类泌尿腺癌 (SUC) 是泌尿腺癌的一个攻击性亚型.
- 它既会影响尿膀,也会影响上游尿道.
研究的目的:
- 提供对SUC当前概念,技术进步和未来方向的全面审查.
- 检查最近的病理学进展,分子概况和SUC的治疗点.
主要方法:
- 关于SUC近期进展的文献综述.
- 分析病理学,分子概况和治疗点.
- 讨论临床影响,化疗和手术方法.
主要成果:
- SUC被确定为基底分子亚型,频繁表达PD-1/PD-L1.
- 突出了对免疫检查点抑制剂的潜在反应.
- 其他潜在的治疗点包括Nectin-4,TROP2,FGFR3和HER2.
结论:
- 新的发展改善了SUC的差异诊断和治疗策略.
- 新辅助化疗后进行激进囊切除术可能会使患者受益.
- 免疫检查点抑制剂为转移性SUC提供了生存益处.
- 针对分子途径的新型疗法使得精确,个性化的治疗成为可能.
相关概念视频
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


